Back

Long-term outcomes of patients treated with pulsed field ablation under the first-in-human clinical trials with prospective invasive remap

31 March 2025 (14:30 - 15:15)
Organised by: Logo
Congress Presentation Part of: Invasive treatment of atrial fibrillation Catheter Ablation of Arrhythmias EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Ivan Sikiric

University Hospital Centre Split, Split (Croatia)

6 More presentations in this session

Presentation thumbnail
Outcomes of patients undergoing catheter ablation to treat atrial fibrillation using zero-fluoroscopy vs conventional approach.
Doctor D. Hincapie (Boston, US)
Abstract Slides Video
Presentation thumbnail
A prospective randomized clinical comparison of catheter ablation of atrial fibrillation using the CENTAURI PEF system and standard radiofrequency ablation
Doctor Z. Starek (Brno, CZ)
Abstract Slides Video
Presentation thumbnail
Visualizable vs. non-visualizable sheaths for atrial fibrillation ablation procedures: a systematic review and meta-analysis
Doctor D. Torma (Pecs, HU)
Abstract Slides Video
Presentation thumbnail
Panoramic atrial mapping offers advantages in the treatment of persistent atrial fibrillation compared with standard pulmonary vein isolation
Doctor R. Gagyi (Szeged, HU)
Abstract Slides Video
Presentation thumbnail
Atrial fibrillation re-ablation: a comparative analysis of the efficacy of initial PVI procedures
Mr D. Inacio Cazeiro (Lisbon, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Invasive treatment of atrial fibrillation

The Event

Event poster

EHRA 2025

31 March 2025 14:30 CET
You may be interested in
thumbnail
Congress Session
Pulsed field ablation for atrial fibrillation ablation: latest findings
thumbnail
Congress Presentation
Electrophysiological findings, incidence, and predictors for AF recurrence after pulsed field versus radiofrequency pulmonary vein isolation. A retrospective analysis.
thumbnail
Congress Presentation
Pulsed field ablation: should it replace radiofrequency and cryoballoon atrial fibrillation ablation?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources